Showing results (1391-1400 of 1,861) with videos related to

Sort By:
Pageof 187
Oral Oncology|January 17, 2015
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancerAntonio Jimeno, Julie E Bauman, Charles Weissman, et al.
AJNR. American Journal of Neuroradiology|June 8, 2019
Flow-Pattern Details in an Aneurysm Model Using High-Speed 1000-Frames-per-Second AngiographyJ M Krebs, A Shankar, S V Setlur Nagesh, et al.
Bone Marrow Transplantation|July 3, 2003
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host diseaseS Kulkarni, R Powles, B Sirohi, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2016
Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter SurveyLatania K Logan, Andrea M Hujer, Steven H Marshall, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancerNicholas W Choong, Everett E Vokes, Daniel J Haraf, et al.
The Journal of Chemical Physics|October 23, 2012
Effect of spin-orbit coupling on the actinide dioxides AnO2 (An=Th, Pa, U, Np, Pu, and Am): a screened hybrid density functional studyXiao-Dong Wen, Richard L Martin, Lindsay E Roy, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2025
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumorsSusan C Scott, Anna Farago, W Victoria Lai, et al.
European Journal of Pediatrics|December 13, 2007
Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritisThomas J Neuhaus, Christoph Berger, Katja Buechner, et al.
Virology|September 3, 2003
Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infectionChristopher M Carthy, Bobby Yanagawa, Honglin Luo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trialsBob T Li, Tristan A Barnes, David L Chan, et al.
Pageof 187